Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Price Monitoring Extension

January 13, 2021
RNS Number : 6057L Renalytix AI PLC 13 January 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Finalization of MCIT rule for coverage pathway

January 13, 2021
RNS Number : 4713L Renalytix AI PLC 13 January 2021   This announcement contains inside information   Renalytix AI plc (" RenalytixAI " or the " Company ")   Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics  

Second Price Monitoring Extn

January 5, 2021
RNS Number : 6755K Renalytix AI PLC 05 January 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension

Price Monitoring Extension

January 5, 2021
RNS Number : 6733K Renalytix AI PLC 05 January 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Partnership Between RenalytixAI and DaVita

January 5, 2021
RNS Number : 5211K Renalytix AI PLC 05 January 2021   This announcement contains inside information   Renalytix AI plc (" RenalytixAI " or the " Company ")   Early Risk Identification at Core of Innovative Kidney Care Partnership Between RenalytixAI, DaVita   First-of-its-kind program combines

RENX to present at 39th JP Morgan Healthcare Conf.

January 4, 2021
RNS Number : 3438K Renalytix AI PLC 04 January 2021     Renalytix AI plc (" RenalytixAI " or the " Company ")   RenalytixAI to Present at the 39 th Annual J.P. Morgan Healthcare Conference     NEW YORK , 4 January 2021 - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial

Result of AGM

December 7, 2020
RNS Number : 8167H Renalytix AI PLC 07 December 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   Result of AGM   Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney
Displaying 1 - 10 of 152